Upadacitinib Shows Safety and Efficacy in Adolescents with Severe Alopecia Areata: Study
Alopecia areata (AA) is a chronic, immune-mediated disorder characterized by non-scarring hair loss, with profound psychological and social consequences, particularly among adolescents. While several therapeutic options exist, efficacy remains variable, and safe long-term treatments are limited for younger patients. Recently, Janus kinase (JAK) inhibitors have emerged as promising therapies, with upadacitinib—a selective JAK1 inhibitor—gaining attention […]